Deva Holdings
Turkey - IstanbulPharmaceutical
Focus: Deva Holdings is a Turkish pharmaceutical manufacturer producing over 600 products across 13 therapeutic areas, with significant concentration in generic and post-LOE assets. The company operates as a mid-sized generics player with a heavily concentrated revenue base.
Profile data last refreshed 19h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Deva Holdings
AI assessmentNot HiringNo open roles listed right now. Follow Deva Holdings to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Deva Holdings's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$369K Part DDeclining
Post-LOE
Accounts for 80% of company revenue despite minimal Part D reimbursement; represents critical but unsustainable dependence on single post-LOE injectable antibiotic.
Help build intelligence for Deva Holdings
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.